Search Results
May 22, 2026, 00:58 ET 2026 ASCO Abstract Highlights | Innovent Announces Preliminary PoC data of IBI363 (PD-1/IL-2α-bias bispecific fusion protein) in Combination with Chemotherapy as First-line Treatment for Advanced NSCLC, Showing Encouraging Efficacy Signals and Favorable Safety
and activate the immune system. Therefore, the first cycle of 3 mg/kg IBI363 could initiate the immune system to expand effector T cells rapidly, enhance T cell infiltration, and form an IO-sensitive immune microenvironment. Subsequently, a 1.5 mg/kg every three weeks (Q3W) regimen is adopted
More news about: Innovent Biologics
May 21, 2026, 23:21 ET ZTE organiza el Congreso de Usuarios de Banda Ancha 2026 en São Paulo, bajo el lema "Monetiza tu banda ancha inteligente"
rentable, acortando el tiempo de comercialización.Light OTN presenta un diseño de alta densidad de 12,8T en 2U con gestión WebGUI minimalista, compatible con una única longitud de onda de 1,6T, implementación sin intervención y plug-and-play, lo que reduce los costes y la complejidad de O&M,
More news about: ZTE Corporation
May 21, 2026, 22:52 ET Achieve earns top ranking for personal loan customer satisfaction from LendingTree
FICO® Score 10 T data, broadens access to fixed-rate loans for an expanded set of consumers. Achieve Personal Loans are originated by a bank partner on the Achieve Personal
More news about: Achieve
May 21, 2026, 21:30 ET The American Hotel Owners Charitable Association (AHOCA) Officially Launches Its Asia Chapter in Hong Kong, Creating a Unified Platform to Connect Industry Leaders in the US and Asia
exchange, working groups, and future closed-door forums.The event was blessed and supported by a number of industry leaders including Hon. Stephen T. Chan, New York State Senator; Hon Ron Kim, New York State Assembly Member; Hon Perry Yiu, MH, JP, Member of Legislative Council (Hong Kong); and Hon
More news about: CSTS Enterprises
May 21, 2026, 19:49 ET Toby Neugebauer Details Strategic Plan to Maximize Value for Fermi Shareholders During Today's Investor Presentation
Melissa A. Neugebauer 2020 Trust (collectively with Mr. Neugebauer, the "Fermi Founder Parties"), together with David A. Daglio, Charles M. Elson, John T. Jimenez, Janet Yang, Sheila Hooda and Juan A. Pujadas (collectively, the "Participants") intend to file a definitive proxy statement on Schedule 14A,
More news about: Toby Neugebauer
May 21, 2026, 19:25 ET Toby Neugebauer Details Strategic Plan to Maximize Value for Fermi Shareholders During Today's Investor Presentation
Melissa A. Neugebauer 2020 Trust (collectively with Mr. Neugebauer, the "Fermi Founder Parties"), together with David A. Daglio, Charles M. Elson, John T. Jimenez, Janet Yang, Sheila Hooda and Juan A. Pujadas (collectively, the "Participants") intend to file a definitive proxy statement on Schedule 14A,
More news about: Toby Neugebauer
May 21, 2026, 18:46 ET AbbVie Announces New Data at ASCO 2026 Demonstrating Breadth and Momentum Across its Next-Generation Oncology Pipeline
next-generation B-cell maturation antigen (BCMA) x CD3 T-cell engager, as monotherapy in a cohort of heavily pre-treated BCMA-exposed R/R MM patients will be presented at the meeting.Etentamig is an investigational BCMA and CD3 bispecific antibody T-cell engager composed of bivalent BCMA-binding
More news about: AbbVie
May 21, 2026, 17:51 ET M&T Bank Corporation to Participate in the Morgan Stanley US Financials Conference
May 21, 2026 /PRNewswire/ -- M&T Bank Corporation ("M&T") (NYSE:MTB) will participate in the Morgan Stanley US Financials Conference being held in New York City. Representatives of M&T are scheduled to deliver a presentation to investors and analysts on
More news about: M&T Bank Corporation
May 21, 2026, 17:35 ET Manulife Announces Executive Leadership Team Changes
Contact: Gina SimonisE: [email protected]T: 1(617) 840-4794
More news about: Manulife Financial Corporation
May 21, 2026, 17:35 ET Manulife Announces Executive Leadership Team Changes
Contact: Gina SimonisE: [email protected]T: 1(617) 840-4794
More news about: Manulife Financial Corporation
May 21, 2026, 17:30 ET Canopy Studies Selected for Oral and Poster Presentations at 2026 ASCO Annual Meeting
[email protected] Kolodziej, M. A., Kwiatkowsky, L., Parrinello, C., Thurow, T., Schaefer, E. S., Beck, J. T., Cherny, N., & Blau, S. (2022). ePRO-based digital symptom monitoring in a community oncology practice to reduce emergency room and
More news about: Canopy
May 21, 2026, 17:30 ET Rutgers Cancer Institute and RWJBarnabas Health to Highlight Advances Shaping the Future of Cancer Research at the 2026 ASCO Annual Meeting
29–June 2 in Chicago and online. Highlights include findings from a late-breaking abstract, Neo-adjuvant rilvegostomig (R) + trastuzumab deruxtecan (T-DXd) in high-risk HER2-negative breast cancer: Results from the I-SPY 2.2 trial, scheduled for presentation on June 1 at 10:45 a.m. CDT.
More news about: Rutgers Cancer Institute and RWJBarnabas Health
May 21, 2026, 17:00 ET New Clinical Data for Izalontamab Brengitecan and Novel ADC Pipeline to be Presented at ASCO 2026
and efficacy results from a Phase II study in China evaluating trastuzumab brengitecan (T-bren; BL-M07D1) in patients with recurrent or metastatic ovarian cancerResults from a Phase II study in China of T-Bren monotherapy or in combination with pertuzumab in patients with treatment-naïve HER2-positive
More news about: SystImmune, Inc.
May 21, 2026, 17:00 ET Boehringer Ingelheim's oncology portfolio shows strong promise across multiple cancers at ASCO 2026
NCT07195695).11About obrixtamig Obrixtamig is an investigational novel Immunoglobin G (IgG)-like bispecific T-cell engager designed to bind concomitantly to DLL3 on tumor cells and CD3 on T-cells, potentially resulting in destruction of tumor cells by the body's own immune system.12 Obrixtamig is
More news about: Boehringer Ingelheim
May 21, 2026, 17:00 ET Sapience Therapeutics Provides Positive Data Update from Phase 2 Trial of Lucicebtide Plus SOC in Patients with Glioblastoma at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
C/EBPβ. Front. Immunol. 11:657. doi: 10.3389/fimmu.2020.006573 Yang Y, Jin X, Xie Y, Ning C, Ai Y, Wei H, Xu X, Ge X, Yi T, Huang Q, Yang X, Jiang T, Wang X, Piao Y, Jin X. The CEBPB+ glioblastoma subcluster specifically drives the formation of M2 tumor-associated macrophages to promote
More news about: Sapience Therapeutics, Inc.
May 21, 2026, 17:00 ET Lilly to showcase oncology portfolio across tumor types and treatment modalities at the 2026 American Society of Clinical Oncology Annual Meeting
SessionKelonia Therapeutics, which Lilly has agreed to acquire, will present updated data for its BCMA-targeted in vivo CAR-T therapy in patients with relapsed and refractory multiple myeloma Additional Lilly presentations include the first clinical
More news about: Eli Lilly and Company
May 21, 2026, 16:58 ET Tigé Boats Signs Professional Wakesurfer Parker Payne
TAPS 3T surf technology. His content will give audiences an unfiltered look at the boat's performance through the eyes of a pro rider.Keep up with
More news about: Tige Boats Inc
May 21, 2026, 16:05 ET Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China
developed for diseases associated with high-risk human papillomavirus (HPV) types 16 and 18. VGX-3100 is designed to elicit an antigen-specific, CD8+ T cell response to clear persistent HPV 16/18 infection, thereby promoting lesion regression and viral clearance.INOVIO licensed VGX-3100 to ApolloBio
More news about: INOVIO Pharmaceuticals, Inc.
May 21, 2026, 15:10 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers - ATRA
diseases in the United States and the United Kingdom. The Company's lead product candidate is tabelecleucel (also referred to as tab-cel or EBVALLO), a T-cell immunotherapy program for the treatment of, inter alia, Epstein-Barr virus positive post-transplant lymphoproliferative disease ("EBV+ PTLD").Atara
More news about: Pomerantz LLP
May 21, 2026, 15:06 ET Alaska Airlines poursuit son expansion mondiale en lançant de nouvelles liaisons européennes et en investissant dans des salons de marque
long-courrier, fait de parcours organisés au millimètre du pas de la porte à la cabine.Le Wi-Fi sera-t-il disponible sur les vols à destination de Londres ? En partenariat avec T-Mobile et Starlink, Alaska Airlines prévoit de proposer le Wi-Fi gratuit dans toute sa flotte, y compris cet
More news about: Alaska Airlines
May 21, 2026, 13:16 ET Silicon Photonics Market Size Forecast at USD 9.6 Billion by 2030 | Wissen Research
technologies, improving scalability and reducing production costs.Optical transceiver technology is advancing with 400G, 800G, and emerging 1.6T speed optical interconnect solutions.These advancements are addressing growing bandwidth demands across AI-powered data centers, cloud
More news about: Wissen Research LLC
May 21, 2026, 13:00 ET Michael Kalen Appointed President of Eagle Rock Wealth
Contact:Miranda DalyDirector of MarketingBranch Professional, RJFS67 E Park Pl Ste 750, Morristown, NJ, 07960T 973.313.8309 | [email protected] offered through
More news about: Eagle Rock, A Greenberg and Rapp Company
